相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sarcopenia and ovarian cancer survival: a systematic review and meta-analysis
Jorne Ubachs et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2019)
Sarcopenic Factors May Have No Impact on Outcomes in Ovarian Cancer Patients
Naomi Nakayama et al.
DIAGNOSTICS (2019)
Recent Issues on Body Composition Imaging for Sarcopenia Evaluation
Koeun Lee et al.
KOREAN JOURNAL OF RADIOLOGY (2019)
Ovarian Cancer Statistics, 2018
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Pre-operative core muscle index in combination with hypoalbuminemia is associated with poor prognosis in advanced ovarian cancer
Lesley B. Conrad et al.
JOURNAL OF SURGICAL ONCOLOGY (2018)
Pitfalls in the measurement of muscle mass: a need for a reference standard
Fanny Buckinx et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2018)
Skeletal Muscle Attenuation (Sarcopenia) Predicts Reduced Overall Survival in Patients with Advanced Epithelial Ovarian Cancer Undergoing Primary Debulking Surgery
Beyhan Ataseven et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Differentiating Sarcopenia and Cachexia Among Patients With Cancer
Sarah J. Peterson et al.
NUTRITION IN CLINICAL PRACTICE (2017)
Sarcopenia in Advanced Serous Ovarian Cancer
Holger Bronger et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2017)
Inflammation and sarcopenia: A systematic review and meta-analysis
Giulia Bano et al.
MATURITAS (2017)
Psoas muscle area is not representative of total skeletal muscle area in the assessment of sarcopenia in ovarian cancer
Iris J. G. Rutten et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2017)
Psoas muscle volume as a predictor of peripheral neurotoxicity induced by primary chemotherapy in ovarian cancers
Tomoyuki Yoshikawa et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Explaining the Obesity Paradox: The Association between Body Composition and Colorectal Cancer Survival (C-SCANS Study)
Bette J. Caan et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
The influence of sarcopenia on survival and surgical complications in ovarian cancer patients undergoing primary debulking surgery
I. J. G. Rutten et al.
EJSO (2017)
Next Steps in Understanding the Obesity Paradox in Cancer
Bette J. Caan et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
Protein requirements beyond the RDA: implications for optimizing health
Stuart M. Phillips et al.
APPLIED PHYSIOLOGY NUTRITION AND METABOLISM (2016)
Muscle composition measured by CT scan is a measurable predictor of overall survival in advanced ovarian cancer
Amanika Kumar et al.
GYNECOLOGIC ONCOLOGY (2016)
Manipulation of Ovarian Function Significantly Influenced Sarcopenia in Postreproductive-Age Mice
Rhett L. Peterson et al.
JOURNAL OF TRANSPLANTATION (2016)
Does selection bias explain the obesity paradox among individuals with cardiovascular disease?
Hailey R. Banack et al.
ANNALS OF EPIDEMIOLOGY (2015)
Inflammation induced loss of skeletal muscle
Priya Londhe et al.
BONE (2015)
Sarcopenia, as defined by low muscle mass, strength and physical performance, predicts complications after surgery for colorectal cancer
D. -D. Huang et al.
COLORECTAL DISEASE (2015)
Skeletal muscle mass and quality: evolution of modern measurement concepts in the context of sarcopenia
Steven B. Heymsfield et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2015)
Skeletal Muscle Depletion and Markers for Cancer Cachexia Are Strong Prognostic Factors in Epithelial Ovarian Cancer
Stefanie Aust et al.
PLOS ONE (2015)
Sarcopenia in women with rheumatoid arthritis
Sevil Ceyhan Dogan et al.
EUROPEAN JOURNAL OF RHEUMATOLOGY (2015)
Lean Tissue Imaging: A New Era for Nutritional Assessment and Intervention
Carla M. M. Prado et al.
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2014)
Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
Lisa Martin et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
The obesity paradox in elderly patients with heart failure: Analysis of nutritional status
Antonio Casas-Vara et al.
NUTRITION (2012)
The genetic pleiotropy of musculoskeletal aging
David Karasik et al.
FRONTIERS IN PHYSIOLOGY (2012)
Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma
S. Antoun et al.
ANNALS OF ONCOLOGY (2010)
Revised FIGO staging for carcinoma of the endometrium
William Creasman
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2009)
A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care
Marina Mourtzakis et al.
APPLIED PHYSIOLOGY NUTRITION AND METABOLISM (2008)
Sarcopenia Is Prevalent in Patients with Crohn's Disease in Clinical Remission
Stephane M. Schneider et al.
INFLAMMATORY BOWEL DISEASES (2008)
Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer
Jennifer K. Litton et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
Carla M. M. Prado et al.
LANCET ONCOLOGY (2008)
Inflammatory markers and loss of muscle mass (sarcopenia) and strength
Laura A. Schaap et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image
W Shen et al.
JOURNAL OF APPLIED PHYSIOLOGY (2004)
分享论文
